Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mutagenesis is the biological process by which the genetic information of an organism is changed, resulting in a mutation. This process can occur spontaneously due to errors in DNA replication or can be induced by exposure to external agents known as mutagens, such as ultraviolet radiation or specific chemical compounds (National Human Genome Research Institute, 2024). While mutagenesis is a fundamental driver of evolution and genetic diversity, it is also a primary cause of cancer and various hereditary diseases when mutations occur in critical genes like oncogenes or tumor suppressors (Nature Education, 2014). In pharmacology and drug development, mutagenesis is not a therapeutic target molecule (such as a receptor or enzyme) but rather a process to be monitored for safety (genotoxicity testing) or utilized in the laboratory (site-directed mutagenesis) to study protein function and drug-target interactions (PubMed, 2023).
Not applicable as mutagenesis is a biological process rather than a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mutagenesis.